While the American Society of Clinical Oncology (ASCO) annual meeting, to be held June 1-5 in Chicago, has a long lineup of immune-oncology hits and misses, there’s plenty to stay on top of outside of immunotherapy, as shown by the ASCO preview report from Pharma Intelligence’s Pharma Biomedtracker and Datamonitor Healthcare analysts.
[Editor’s note: See our companion piece for immuno-oncology highlights for ASCO 2018.]